Zykadia

药品简介

Originator: Zykadia by Novartis Pharmaceuticals · Manufacturer: Novartis Pharma. Indication & Dosage: Zykadia (Ceritinib), is a prescription medicine used to treat anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) for which patients who are unable to tolerate or have progressed on prior crizotinib therapy. Zykadia Manufactured by Novartis Pharma Ltd. in Switzerland. Ceritinib has to take 450 mg orally once daily with food. *First dose reduction: 300 mg qDay *Second dose reduction: 150 mg qDay *Unable to tolerate 150 mg/ day: Discontinue Side Effects: The most common adverse reactions of Ceritinib are: Diarrhea , nausea , vomiting , abdominal pain, loss of appetite , heartburn, constipation, or tiredness. The above information comes from the Internet. Please consult with doctor for medical advice.

本信息仅供参考，不构成医疗建议。请务必咨询合格的医疗专业人士。